Feroz Jameel

Title: Feroz Jameel: Innovator in Pharmaceutical Formulations

Introduction

Feroz Jameel is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative work has led to the development of unique formulations that enhance the administration of essential medications.

Latest Patents

Feroz Jameel holds 1 patent for his invention titled "Pharmaceutical formulations for subcutaneous administration." This patent focuses on compositions of levodopa 4'-monophosphate and carbidopa 4′-monophosphate, which are formulated in a weight by weight ratio of about 20:1. The methods described in this patent aim to treat Parkinson's disease and associated conditions through subcutaneous administration of these compositions.

Career Highlights

Throughout his career, Feroz Jameel has worked with prominent companies in the pharmaceutical industry, including AbbVie Inc. and Abb Vie Deutschland GmbH & Co. KG. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Feroz has collaborated with several professionals in his field, including Ehab Moussa and Matthew Rosebraugh. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Feroz Jameel's innovative contributions to pharmaceutical formulations demonstrate his commitment to improving treatment options for patients with Parkinson's disease. His work continues to influence the field and offers hope for enhanced therapeutic strategies.